Consumption of NCD medicines in Azerbaijan, Georgia, and Uzbekistan in 2019–2021, outpatient setting, DDDs per 1000 inhabitants per day.

Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008-2018: a sales data analysis

Ma, Tian-Tian
Wang, Zixuan
Qin, Xiwen
Ju, Chengsheng
Lau, Wallis CY
Man, Kenneth KC
Castle, David
Chang, Wing Chung
Chan, Adrienne YL
Cheung, Edmund CL
Chui, Celine SL
Wong, Ian CK

April 2023

STUDY OBJECTIVES: To investigate the trends in the consumption of benzodiazepines (BZDs) and Z-drugs...

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for different measures of economic performance.

Simiao Chen (5921225)
Michael Kuhn (189862)
Klaus Prettner (5921228)
David E. Bloom (316357)

November 2018

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for di...

Drug utilization patterns in Zabljak municipality, Serbia and Montenegro

Moidrag, S
Jankovic, S V
Jankovic, S M

April 2007

Background: Information about drug utilization among the out patients in Serbia & Montenegro is sca...

Consumption of NCD medicines, DDD per 1000 inhabitants per day, by specific health conditions in 2019–2021.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Consumption of NCD medicines, DDD per 1000 inhabitants per day, by specific health conditions in 201...

Percentage change in average cost of 1 day of treatment for medicines used to treat NCDs since 2019.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Azerbaijan and Georgia–difference between average price in 2021 compared to 2019; Uzbekistan–differe...

Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.

Ninell Kadyrova
Dzintars Gotham
Stanislav Kniazkov
Elsever Aghayev
Polad Hajibalayev
Zohid Ermatov
Natasha Azzopardi Muscat

January 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Number of NCD medicines with available data on consumption and prices, by disease category and country.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Number of NCD medicines with available data on consumption and prices, by disease category and count...

Average cost of 1 day of treatment with NCD medicines in 2019–2021, USD.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Costs shown are average cost per DDD weighted by the volume of consumption for each medicine include...

Average cost of 1 day of treatment with NCD medicines and consumption levels, 2019–2021.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

The data refer to the sum of consumption of medicines in DDDs used in treatment of diabetes (A10), i...

Appendix 3.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Appendix 1.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Appendix 2.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Incidence and prevalence of NDD-CKD among the general population in France per year (2015−2017).

Karim Dardim (16496517)
Jérôme Fernandes (4339828)
Arnaud Panes (16496520)
Julien Beisel (16496523)
Aurélie Schmidt (3666916)
Josephine Wolfram (16496526)
Lora Todorova (16496529)
Laurence Dubel (16496532)
Thierry Lobbedez (2579155)

July 2023

Incidence and prevalence of NDD-CKD among the general population in France per year (2015−2017).</p

Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean NCCs, and by age and sex in Denmark on 1 January 2013.

Michael Falk Hvidberg (13794431)
Anne Frølich (2161042)
Sanne Lykke Lundstrøm (13794434)
Nina Kamstrup-Larsen (6932717)

September 2022

Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean N...

Trends in the diabetes mellitus morbidity (cases per 1000 inhabitants), oral antidiabetic drugs consumption (DDD/TID) and costs (USD/TID) in Poland, 2012–2015.

Andrzej Śliwczyński (2794438)
Melania Brzozowska (4068193)
Andrzej Jacyna (4068199)
Petre Iltchev (4068187)
Tymoteusz Iwańczuk (4068190)
Waldemar Wierzba (4068205)
Michał Marczak (4068196)
Katarzyna Orlewska (4068208)
Piotr Szymański (572213)
Ewa Orlewska (4068202)

June 2017

<p>Trends in the diabetes mellitus morbidity (cases per 1000 inhabitants), oral antidiabetic drugs c...

Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008-2018: a sales data analysis

Ma, Tian-Tian
Wang, Zixuan
Qin, Xiwen
Ju, Chengsheng
Lau, Wallis CY
Man, Kenneth KC
Castle, David
Chang, Wing Chung
Chan, Adrienne YL
Cheung, Edmund CL
Chui, Celine SL
Wong, Ian CK

April 2023

STUDY OBJECTIVES: To investigate the trends in the consumption of benzodiazepines (BZDs) and Z-drugs...

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for different measures of economic performance.

Simiao Chen (5921225)
Michael Kuhn (189862)
Klaus Prettner (5921228)
David E. Bloom (316357)

November 2018

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for di...

Drug utilization patterns in Zabljak municipality, Serbia and Montenegro

Moidrag, S
Jankovic, S V
Jankovic, S M

April 2007

Background: Information about drug utilization among the out patients in Serbia & Montenegro is sca...

Consumption of NCD medicines, DDD per 1000 inhabitants per day, by specific health conditions in 2019–2021.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Consumption of NCD medicines, DDD per 1000 inhabitants per day, by specific health conditions in 201...

Percentage change in average cost of 1 day of treatment for medicines used to treat NCDs since 2019.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Azerbaijan and Georgia–difference between average price in 2021 compared to 2019; Uzbekistan–differe...

Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.

Ninell Kadyrova
Dzintars Gotham
Stanislav Kniazkov
Elsever Aghayev
Polad Hajibalayev
Zohid Ermatov
Natasha Azzopardi Muscat

January 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Number of NCD medicines with available data on consumption and prices, by disease category and country.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Number of NCD medicines with available data on consumption and prices, by disease category and count...

Average cost of 1 day of treatment with NCD medicines in 2019–2021, USD.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

Costs shown are average cost per DDD weighted by the volume of consumption for each medicine include...

Average cost of 1 day of treatment with NCD medicines and consumption levels, 2019–2021.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

The data refer to the sum of consumption of medicines in DDDs used in treatment of diabetes (A10), i...

Appendix 3.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Appendix 1.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Appendix 2.

Ninell Kadyrova (17598812)
Dzintars Gotham (3536519)
Stanislav Kniazkov (17460414)
Elsever Aghayev (17598815)
Polad Hajibalayev (17598818)
Zohid Ermatov (17598821)
Natasha Azzopardi Muscat (17598824)

December 2023

BackgroundAccess to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have differe...

Incidence and prevalence of NDD-CKD among the general population in France per year (2015−2017).

Karim Dardim (16496517)
Jérôme Fernandes (4339828)
Arnaud Panes (16496520)
Julien Beisel (16496523)
Aurélie Schmidt (3666916)
Josephine Wolfram (16496526)
Lora Todorova (16496529)
Laurence Dubel (16496532)
Thierry Lobbedez (2579155)

July 2023

Incidence and prevalence of NDD-CKD among the general population in France per year (2015−2017).</p

Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean NCCs, and by age and sex in Denmark on 1 January 2013.

Michael Falk Hvidberg (13794431)
Anne Frølich (2161042)
Sanne Lykke Lundstrøm (13794434)
Nina Kamstrup-Larsen (6932717)

September 2022

Overview of mean NCCs and SD of disease groups and medicines: The number of patients, overall mean N...

Trends in the diabetes mellitus morbidity (cases per 1000 inhabitants), oral antidiabetic drugs consumption (DDD/TID) and costs (USD/TID) in Poland, 2012–2015.

Andrzej Śliwczyński (2794438)
Melania Brzozowska (4068193)
Andrzej Jacyna (4068199)
Petre Iltchev (4068187)
Tymoteusz Iwańczuk (4068190)
Waldemar Wierzba (4068205)
Michał Marczak (4068196)
Katarzyna Orlewska (4068208)
Piotr Szymański (572213)
Ewa Orlewska (4068202)

June 2017

<p>Trends in the diabetes mellitus morbidity (cases per 1000 inhabitants), oral antidiabetic drugs c...

Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008-2018: a sales data analysis

Ma, Tian-Tian
Wang, Zixuan
Qin, Xiwen
Ju, Chengsheng
Lau, Wallis CY
Man, Kenneth KC
Castle, David
Chang, Wing Chung
Chan, Adrienne YL
Cheung, Edmund CL
Chui, Celine SL
Wong, Ian CK

April 2023

STUDY OBJECTIVES: To investigate the trends in the consumption of benzodiazepines (BZDs) and Z-drugs...

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for different measures of economic performance.

Simiao Chen (5921225)
Michael Kuhn (189862)
Klaus Prettner (5921228)
David E. Bloom (316357)

November 2018

Disease burden (100% of prevalence averted) due to all NCDs in the United States in 2015–2050 for di...

Drug utilization patterns in Zabljak municipality, Serbia and Montenegro

Moidrag, S
Jankovic, S V
Jankovic, S M

April 2007

Background: Information about drug utilization among the out patients in Serbia & Montenegro is sca...

Consumption of NCD medicines in Azerbaijan, Georgia, and Uzbekistan in 2019–2021, outpatient setting, DDDs per 1000 inhabitants per day.

Abstract

Extracted data

Consumption of NCD medicines in Azerbaijan, Georgia, and Uzbekistan in 2019–2021, outpatient setting, DDDs per 1000 inhabitants per day.

Abstract

Extracted data

Related items

Related items